Craniofrontonasal syndrome (CFNS, MIM 304110) is an X-linked craniofacial disorder that shows paradoxically greater severity in heterozygous females than in hemizygous males. Mutations have been identified in the EFNB1 gene that encodes a member of the ephrin-B family of transmembrane ligands for Eph receptor tyrosine kinases. Here, we describe two unrelated families, in both of which a mother and her son have proven mutations in EFNB1. The mothers have classical features of CFNS; although the sons have no major craniofacial features other than telecanthus, both had a congenital diaphragmatic hernia (CDH). Our cases represent the first in which CDH has been confirmed in males with mutations in EFNB1, highlighting an important role for signalling by ephrin-B1 in the development of the diaphragm.
Introduction
In 1979, craniofrontonasal syndrome (CFNS, MIM 304110) was identified as a subgroup of frontonasal dysplasia by Cohen, 1 who coined the term craniofrontonasal dysplasia.
The condition is characterised in females by hypertelorism, coronal craniosynostosis, craniofacial asymmetry, frontal bossing, downslanting palpebral fissures, broad bifid nose, low posterior hairline with an anterior widow's peak, frizzy hair, occasional cleft lip and palate, longitudinally grooved fingernails and other digital anomalies. 2 -7 The fewer males described have mostly been more mildly affected with hypertelorism and, occasionally, cleft lip or palate. 2 -5,7 This greater severity in females than males has always appeared surprising, given evidence from pedigree analysis that CFNS is an X-linked disorder. 3, 7 The X-linkage of CFNS was recently confirmed by the identification of mutations in the EFNB1 gene, which maps to Xq13.1, in both familial and sporadic cases. 8 -11 EFNB1 encodes ephrin-B1, a transmembrane ligand for Eph receptor tyrosine kinases that itself exhibits receptor-like effects. Significantly, mice with null mutations of ephrin-B1 have malformations of the axial and appendicular skeleton that also show greater severity in heterozygous females than in either homozygous females or hemizygous males. 12, 13 Because of X-inactivation, heterozygous females are uniquely mosaic for cells that either do, or do not, make functional protein; this is proposed to lead to abnormal sorting of cell populations and disturbance of normal tissue boundary formation. The term cellular interference has been suggested for this process. 9 This ectopic signalling mechanism of pathogenesis makes it difficult to draw firm conclusions about the normal functions of ephrin-B1 from the phenotype of CFNS females. By contrast, the usually mild male phenotype associated with ephrin-B1 mutations in both humans and mice has been attributed to functional redundancy with other ephrins. Here we report a more severe phenotype, congenital diaphragmatic hernia (CDH), in two unrelated males hemizygous for EFNB1 mutations. This suggests a nonredundant role for ephrin-B1 in the development of the diaphragm.
Case reports and mutation analysis demonstrated a frameshifting mutation (432delG, predicting L145WfsX14) in exon 3, which was heterozygous in the mother and hemizygous in her son (Figure 1e and f). While sacrococcygeal teratoma is not a recognised association of CFNS, we note that a similarly affected female CFNS patient with a confirmed EFNB1 mutation was described previously. 8 
Family 2
A male infant (case 2) of nonconsanguineous Caucasian parents was born at 37 weeks' gestation with left-sided CDH, talipes equinovarus and swallowing difficulties. The CDH was repaired at age 3 days with a Gore-Tex patch, fundoplication and gastrostomy tube placement, with a good result. On examination at 2 years of age, he had telecanthus (inner canthal distance of 33 mm; more than þ 2 s.d. above the mean) but no other dysmorphic features (Figure 2a Expanding the phenotype of craniofrontonasal syndrome PC Vasudevan et al
Discussion
The identification of two unrelated males hemizygous for EFNB1 mutations, both of whom have CDH, provides new insight into the pathogenesis of this disorder. CDH occurs about once in 3000 newborns and is associated with a 30 -60% mortality rate with significant morbidity among survivors.
14 CDH has been described in association with many chromosome abnormalities and in a number of syndromes; 15 -17 however, the only known genetic defect associated with nonsyndromic congenital diaphragmatic defect in humans is mutation in the FOG2 gene. 18 Studies in rodents have shown three general causes of developmental error leading to CDH. Failure of the normal closure of the pleuroperitoneal folds from embryonic day 12.5 in rats (equivalent to week 5 in humans) causes the common posterolateral defect seen in the cases described here. Alternatively, defects in the formation of the central tendon, or in migration of the muscle and nerve precursor cells from the cervical somites to the diaphragm, can also result in CDH. 19 CDH was previously described in four females with CFNS, 8,20 -22 but the developmental interpretation of these cases is complicated by the presence of X-inactivation (see Introduction). The only previous report of CDH in affected males was by Morris et al, 23 who described a family of six individuals with apparent CFNS including two affected brothers with CDH. However, several authors have disputed this diagnosis as only one family member had craniosynostosis and the affected males had additional manifestations not described in CFNS, including short stature, delayed bone age, shawl scrotum and hypospadias; an alternative diagnosis of brachycephalofrontal dysplasia (Teebi syndrome; MIM 145420) has been proposed. 5, 7, 22 To our knowledge, no molecular analysis has been undertaken in this family, so the issue remains unresolved. The two male CDH cases presented here represent the first in which the diagnosis has been confirmed by the finding of pathogenic mutations in EFNB1. Both mutations are likely to lead to the loss of function. In family 1, the frameshift mutation truncates the C-terminal portion of the extracellular domain and, in addition, may lead to nonsensemediated decay of the mutant transcript; in family 2, the deleted valine is within a b-sheet 24 and therefore normal folding of the protein is likely to be disrupted. The spectrum of EFNB1 mutations observed in males without CDH 9 -11 is qualitatively similar, arguing against a distinct pathogenic action of the mutations observed here: presumably, the occurrence of CDH in our cases was caused by additional, unknown modifier effects.
In conclusion, our data indicate that the male CFNS phenotype is not always mild and that loss of ephrin-B1 function may interfere with normal diaphragmatic development. These observations need to be incorporated into genetic counselling for families with CFNS. Previous studies of ephrin-B1 expression in mouse 25 and chick do not indicate which aspects of diaphragmatic development might be affected, and diaphragmatic defects were not reported in either of the published murine Efnb1 mutants. 14, 15 Our observations provide impetus to further experimental studies of ephrin-B1 signalling in the development of the diaphragm.
